Malignancies in beta-thalassemia patients: a single-center experience and a concise review of the literature.
Thalassemia represents the world's most common monogenic disease, characterized by absence of or decreased globin chain production. The lifespan of thalassemia patients has been extended as a result of current supportive treatment. We report three cases of cancer (non-Hodgkin lymphoma, Hodgkin disease, and seminoma) in thalassemic patients. Factors that may contribute to the pathogenesis of cancer seem to be infections and iron overload through mechanisms of oxidative damage; immunomodulation or coexistence of the two diseases may only be coincidental.
Benetatos
L
L
Department of Hematology, University Hospital of Ioannina, Ioannina, Greece. me01532@cc.uoi.gr
Alymara
V
V
Vassou
A
A
Bourantas
K L
KL
D000328:Adult; D005260:Female; D006689:Hodgkin Disease / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications*; D018714:Radiotherapy, Adjuvant; D018239:Seminoma / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D013736:Testicular Neoplasms / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D017086:beta-Thalassemia / Q000150:complications* / Q000175:diagnosis / Q000503:physiopathology* / Q000628:therapy